Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 52% ± 21% | |
peripheral blood | 17 studies | 28% ± 7% | |
intestine | 13 studies | 42% ± 25% | |
kidney | 6 studies | 30% ± 12% | |
uterus | 6 studies | 56% ± 24% | |
placenta | 4 studies | 53% ± 24% | |
eye | 4 studies | 31% ± 17% | |
adipose | 4 studies | 26% ± 4% | |
prostate | 4 studies | 57% ± 11% | |
breast | 4 studies | 61% ± 11% | |
ovary | 3 studies | 43% ± 17% | |
heart | 3 studies | 20% ± 1% | |
esophagus | 3 studies | 50% ± 13% | |
pancreas | 3 studies | 19% ± 3% | |
liver | 3 studies | 29% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 21538.78 | 960 / 966 | 100% | 1047.10 | 525 / 527 |
stomach | 100% | 8006.99 | 358 / 359 | 99% | 767.23 | 282 / 286 |
lung | 100% | 14079.58 | 577 / 578 | 98% | 453.24 | 1131 / 1155 |
esophagus | 100% | 12701.74 | 1444 / 1445 | 98% | 438.70 | 179 / 183 |
bladder | 100% | 11486.86 | 21 / 21 | 95% | 519.79 | 479 / 504 |
skin | 100% | 22148.90 | 1809 / 1809 | 94% | 845.04 | 445 / 472 |
uterus | 100% | 10265.87 | 170 / 170 | 91% | 397.79 | 419 / 459 |
breast | 100% | 18600.31 | 459 / 459 | 88% | 269.63 | 985 / 1118 |
kidney | 94% | 5911.25 | 84 / 89 | 93% | 369.58 | 838 / 901 |
ovary | 100% | 11973.39 | 180 / 180 | 87% | 231.80 | 372 / 430 |
thymus | 92% | 4297.99 | 600 / 653 | 84% | 524.79 | 507 / 605 |
prostate | 100% | 8184.34 | 245 / 245 | 71% | 151.86 | 358 / 502 |
pancreas | 42% | 1588.96 | 139 / 328 | 94% | 627.19 | 167 / 178 |
adipose | 100% | 19554.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 295.72 | 1 / 1 |
adrenal gland | 76% | 2991.36 | 196 / 258 | 23% | 47.26 | 54 / 230 |
blood vessel | 99% | 8134.14 | 1322 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 7412.60 | 850 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 347.52 | 43 / 45 |
peripheral blood | 94% | 5423.99 | 873 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 211.55 | 26 / 29 |
spleen | 70% | 2370.72 | 168 / 241 | 0% | 0 | 0 / 0 |
brain | 31% | 1201.20 | 824 / 2642 | 31% | 113.66 | 220 / 705 |
eye | 0% | 0 | 0 / 0 | 49% | 152.05 | 39 / 80 |
muscle | 36% | 1415.14 | 292 / 803 | 0% | 0 | 0 / 0 |
liver | 1% | 68.50 | 3 / 226 | 33% | 79.51 | 133 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006397 | Biological process | mRNA processing |
GO_0030855 | Biological process | epithelial cell differentiation |
GO_0045087 | Biological process | innate immune response |
GO_0050918 | Biological process | positive chemotaxis |
GO_0050860 | Biological process | negative regulation of T cell receptor signaling pathway |
GO_0042129 | Biological process | regulation of T cell proliferation |
GO_0045806 | Biological process | negative regulation of endocytosis |
GO_2000521 | Biological process | negative regulation of immunological synapse formation |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_0070232 | Biological process | regulation of T cell apoptotic process |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0008380 | Biological process | RNA splicing |
GO_0071677 | Biological process | positive regulation of mononuclear cell migration |
GO_2001200 | Biological process | positive regulation of dendritic cell differentiation |
GO_0048245 | Biological process | eosinophil chemotaxis |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_1903614 | Biological process | negative regulation of protein tyrosine phosphatase activity |
GO_2001189 | Biological process | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO_0071674 | Biological process | mononuclear cell migration |
GO_0002548 | Biological process | monocyte chemotaxis |
GO_1902041 | Biological process | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO_0090280 | Biological process | positive regulation of calcium ion import |
GO_0048246 | Biological process | macrophage chemotaxis |
GO_0001772 | Cellular component | immunological synapse |
GO_0005615 | Cellular component | extracellular space |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0005634 | Cellular component | nucleus |
GO_0019863 | Molecular function | IgE binding |
GO_0019903 | Molecular function | protein phosphatase binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0004864 | Molecular function | protein phosphatase inhibitor activity |
GO_0048030 | Molecular function | disaccharide binding |
GO_0042056 | Molecular function | chemoattractant activity |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0003723 | Molecular function | RNA binding |
GO_0043236 | Molecular function | laminin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LGALS3 |
Protein name | Galectin 3 Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein) (GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen) Galectin |
Synonyms | MAC2 |
Description | FUNCTION: Galactose-specific lectin which binds IgE. May mediate with the alpha-3, beta-1 integrin the stimulation by CSPG4 of endothelial cells migration. Together with DMBT1, required for terminal differentiation of columnar epithelial cells during early embryogenesis (By similarity). In the nucleus: acts as a pre-mRNA splicing factor. Involved in acute inflammatory responses including neutrophil activation and adhesion, chemoattraction of monocytes macrophages, opsonization of apoptotic neutrophils, and activation of mast cells. Together with TRIM16, coordinates the recognition of membrane damage with mobilization of the core autophagy regulators ATG16L1 and BECN1 in response to damaged endomembranes. . |
Accessions | G3V407 ENST00000554715.1 P17931 Q6FGL0 G3V3R6 ENST00000254301.14 ENST00000553493.5 Q6NVH9 |